Research in dentistry will continue through the work of young researchers already begun in the past year, and which will continue around the painful body in a qualitative and ethical perspective.
Projects
The ethics researchers intend to continue their research on the observation of the diversity of procedures for informing relatives in Europe, in the field of rare diseases.
This inter-team project will focus on a specific case where the patient's body is treated using the resources of another's body. In this case, the body is no longer simply the receptacle of treatments but becomes itself a means of treatment available to patients in a life-threatening situation (leukemia, sickle cell disease, etc.).
In the event of death, other social norms unfold because respect for the body does not disappear with death. The SARS-CoV-2 pandemic has given an insight into the cultural invariants in the respect due to the body of the deceased. The duty of decency that the living recognize towards the cadaveric body is imposed even when the person has donated his or her body to science, within a recently reinforced normative framework. During the next contract, the removal of elements from the cadaveric body at the request of the judicial authorities will be the subject of a renewed deontological approach through the digitization of forensic resources.
This project is led by Maria De Grandis (PhD, CR EFS), Sylvie Fernandes (PhD, DR EFS) and Stéphanie Morin (PhD, CR EFS), with the technical support of Alexandra Grimaldi (Research Assistant EFS), Cécile Durousseau (Research Assistant EFS) and Thomas Granier (Research Assistant EFS)
In this project we are interested in red blood cell diseases and the vascular abnormalities in which they may be involved, with a particular focus on dyserythropoiesis and blood cell interactions in the circulation. Initially we will concentrate our efforts on sickle cell disease as a pathological model, then we will extend our methodology to explore other diseases, notably membrane diseases, in which potential defects in erythropoiesis have never been examined.
Our transfusion research is focused on improving transfusion products, with RBC as the primary focus.